The Penn Institute for RNA Innovation is pleased to announce the appointment of Dr. Bin Tian as leader of the RNA Binding Proteins group. Tian will be joining our team of researchers working to better understand the role RNA plays at the genetic level.
Tian is a molecular systems biologist whose research is focused on understanding how gene expression is regulated at the RNA level. His lab was among the first to discover the widespread nature of alternative polyadenylation (APA) using bioinformatic and genomic approaches. They have also revealed multiple molecular mechanisms that regulate APA and cellular functions of APA isoforms in a number of biological systems.
Tian received his B.S. degree in biochemistry from East China University of Science and Technology and his Ph.D. degree in molecular biology from Rutgers Biomedical and Health Sciences (formerly UMDNJ). He was a postdoctoral fellow in bioinformatics and genomics at Johnson & Johnson Pharmaceutical Research & Development in La Jolla, California. In 2003, he established his research group at Rutgers New Jersey Medical School, where he rose through the ranks and became a tenured professor in 2014. Tian joined The Wistar Institute in 2020.
We are excited to have Dr. Tian join our team and look forward to his contributions to our research.
Please join us in welcoming Dr. Tian to the Penn Institute for RNA Innovation.